|Day Low/High||4.57 / 4.79|
|52 Wk Low/High||1.74 / 10.57|
The Menlo Park, Calif.-based firm had a third-quarter net loss of $22 million, compared with $17.5 million in the year-ago period. Product, service and other revenue rose 9% year-over-year to $23.5 million.
The Henderson, Nev.-based company said interim data from a Phase 2 study showed an objective response rate of 73%.
Bloomberg's Boner, Wal-Mart's World, Depressing Dell and Phony Sony are among Gregg Greenberg's 5 Dumbest Things on Wall Street this week.
Soda bans, electronics retailer upgrades and a stock that will not be music to anyone's ears. TheStreet's Gregg Greenberg has this week's 5 Dumbest Things on Wall Street.
Here is this week's roundup of the dumbest actions on Wall Street.
Portfolio manager David Peltier analyzes a volatile, low-dollar drug stock.
Adam Feuerstein, senior columnist for TheStreet, says biotech earnings are the next big thing to watch in biotech.
I've got my eye on these, though I wouldn't act until the market decides on a direction.
There isn't necessarily any correlation between the way stocks trade and the feeling about the economy.